This page lists BPC-157 purity, pentadecapeptide sequence, molecular mass, category, SKU, stock status, and lab-report routing so researchers can review procurement details before ordering
Does AOD-9604 raise IGF-1 levels
The peptide has never been tested on humans except for one small trial that was never published
Primary use Reconstituting injectable drugs: In practice, bacteriostatic water is used whenever a medications manufacturer directs to reconstitute or dilute an injectable drug
About 10% of tirzepatide participants had a heart-rate increase above 20 bpm during escalation, compared with 3% on placebo. A lean Japanese cohort reached +10 to +13 bpm, and 23% of Japanese participants at 15 mg crossed the abnormal-pulse threshold versus 7% of other participants, despite only 17% higher exposure. Lean and East Asian bodies showed greater cardiovascular sensitivity than exposure alone predicted
Health Canada has not approved BPC-157 as a health product or prescription drug, classifying it as an unauthorized health product
